文献速递产科

机械性与药物性引产方法的随机对照试验

Mechanical and Pharmacologic Methods of Labor Induction: A Randomized Controlled Trial.
PubMed 文献 · Obstet Gynecol · 2016-01-01

该随机试验比较四种引产方法:单用米索前列醇、单用Foley导管、米索前列醇与宫颈Foley导管联用、Foley导管与缩宫素联用。共491例足月单胎头位、 Bishop评分≤6且宫颈扩张≤2 cm的孕妇纳入分析。联合方案的中位分娩时间短于单药方案(P<.001);校正产次并对剖宫产进行删失后,米索前列醇-Foley组较单用米索前列醇或单用Foley的分娩可能性接近两倍。

要点

  • 米索前列醇-Foley组中位分娩时间13.1小时,短于单用米索前列醇的17.6小时和单用Foley的17.7小时(P<.001)。
  • 米索前列醇-Foley组分娩可能性约为单用米索前列醇的1.92倍(HR 1.92, 95%CI 1.42-2.59)。
  • Foley-缩宫素组与单药方案相比无统计学差异。

核心结论

  • 校正产次并对剖宫产进行删失后,米索前列醇-宫颈Foley使分娩可能性达到任一单药方法的两倍。

研究设计与样本

  • 随机试验比较四种引产方法:单用米索前列醇、单用Foley、米索前列醇与宫颈Foley同时使用、Foley与缩宫素同时使用。
  • 纳入标准为足月(≥37周)、单胎、头位、无阴道分娩禁忌、胎膜完整、Bishop评分≤6且宫颈扩张≤2 cm的孕妇。
  • 计划每组123例(n=492),以两两比较(P≤.008)检测分娩时间缩短4小时为有临床意义。
  • 2013年5月至2015年6月筛查997例,最终491例随机分组并分析。

主要发现

  • 联合方案的中位分娩时间快于单药方案:米索前列醇-Foley 13.1小时、Foley-缩宫素14.5小时、米索前列醇17.6小时、Foley 17.7小时(P<.001)。
  • 校正产次并对剖宫产进行删失后,米索前列醇-Foley组较单用米索前列醇的分娩可能性更高(HR 1.92, 95%CI 1.42-2.59)。
  • 校正产次并对剖宫产进行删失后,米索前列醇-Foley组较单用Foley的分娩可能性更高(HR 1.87, 95%CI 1.39-2.52)。
  • Foley-缩宫素与单药方法相比无统计学差异。

临床怎么用

  • 原文结论未据此给出临床推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effectiveness of four commonly used induction methods. METHODS: This randomized trial compared four induction methods: misoprostol alone, Foley alone, misoprostol-cervical Foley concurrently, and Foley-oxytocin concurrently. Women undergoing labor induction with full-term (37 weeks of gestation or greater), singleton, vertex-presenting gestations, with no contraindication to vaginal delivery, intact membranes, Bishop score 6 or less, and cervical dilation 2 cm or less were included. Women were enrolled only once during the study period. Our primary outcome was time to delivery. Neither patients nor health care providers were blinded to assigned treatment group because examinations are required for placement of all methods; however, research personnel were blinded during data abstraction. A sample size of 123 per group (n=492) was planned to compare the four groups pairwise (P≤.008) with a 4-hour reduction in delivery time considered clinically meaningful. RESULTS: From May 2013 through June 2015, 997 women were screened and 491 were randomized and analyzed. Demographic and clinical characteristics were similar among the four treatment groups. When comparing all induction method groups, combination methods achieved a faster median time to delivery than single-agent methods (misoprostol-Foley: 13.1 hours, Foley-oxytocin: 14.5 hours, misoprostol: 17.6 hours, Foley: 17.7 hours, P<.001). When censored for cesarean delivery and adjusting for parity, women who received misoprostol-Foley were almost twice as likely to deliver before women who received misoprostol alone (hazard ratio 1.92, 95% confidence interval [CI] 1.42-2.59) or Foley alone (hazard ratio 1.87, 95% CI 1.87 1.39-2.52), whereas Foley-oxytocin was not statistically different from single-agent methods. CONCLUSION: After censoring for cesarean delivery and adjusting for parity, misoprostol-cervical Foley resulted in twice the chance of delivering before either single-agent method. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, https://clinicaltrials.gov, NCT01916681.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Levine LD, Downes KL, Elovitz MA, et al. Mechanical and Pharmacologic Methods of Labor Induction: A Randomized Controlled Trial. Obstet Gynecol. 2016. PMID: 27824758

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。